• DSMZ and P.H.A.G.E. are cooperating in order to establish a Therapeutic Phage Bank, a collection of phages being in focus of potential application.
  • 1
  • 2

P.H.A.G.E. Who we are

We are an international non-profit organization to support phage research and phage therapy in Europe.

Read More

Events P.H.A.G.E. supports

We are involved in a number of Events and Conferences.

Read More

Literature For Expert Reading

Our collection of Literature can surely interest you.

Read More

P.H.A.G.E. How we work

Want to know more about PHAGE as non-profit organization...

Read More

PHAGOBURN is the project name of the first European clinical study on phage therapy to treat Escherichia coli and Pseudomonas aeruginosa skin infections in burn patients.

The project is funded by the 7th Framework Programme for Research and Development (Health Programme). It has been launched on June 1st, 2013 and will last 27 months.

Under the coordination of the French Ministry of Defence (Army Health Service – Percy Military Hospital) collaborating with Pherecydes Pharma (French SME), PHAGOBURN gathers six other international burn treatment centres – including the Royal Military Academy/Queen Astrid Military Hospital (Belgium) and the Lausanne University Hospital (Switzerland) – as well as a second French SME, Clean Cells.

The PHAGOBURN study aims at evaluating phage therapy (therapeutic use of bacteriophages) to treat skin infections caused by Escherichia coli and Pseudomonas aeruginosa bacteria in burn patients.

More information can be found online (http://cordis.europa.eu/search/index.cfm?fuseaction=proj.document&PJ_RCN=13907101)
or in the Press Release Kit.

One of the major approaches of P.H.A.G.E. in 2013 is the establishment of a Therapeutic Phage Bank under a Memorandum of Understanding between P.H.A.G.E. and the Leibniz Institute DSMZ. P.H.A.G.E. is an initiative with high relevance for the society. The establishment of a Therapeutic Phage Bank within a renowned and securely funded biological resource centre that is experienced in phage biology will strongly support the goals of P.H.A.G.E. insofar as phages that might be or definitely are suitable for application in humans have to be kept safe, secure and authentic for future use. The infrastructural preconditions for running such a phage collection is given at the Leibniz Institute DSMZ.